Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Bladder cancer updates from the second half of 2026

Prof Alison Birtle, Dr Ignacio Duran, Prof Axel Merseburger, Dr José Domínguez-Escrig and Prof Morgan Rouprêt
Bladder cancer updates from the second half of 2026 ( Prof Alison Birtle, Dr Ignacio Duran, Prof Axel Merseburger, Dr José Domínguez-Escrig and Prof Morgan Rouprêt )
18 Nov 2026

ESMO 2026: Prostate cancer roundup

Dr Natalia Gandur - Instituto de Oncología 'Ángel H. Roffo', Buenos Aires, Argentina
ESMO 2026: Prostate cancer roundup ( Dr Natalia Gandur - Instituto de Oncología 'Ángel H. Roffo', Buenos Aires, Argentina )
2 Nov 2026

Outpatient administration of xaluritamig for mCRPC: Feasibility and safety

Prof William Kelly – Thomas Jefferson University, Philadelphia, USA
Outpatient administration of xaluritamig for mCRPC: Feasibility and safety ( Prof William Kelly – Thomas Jefferson University, Philadelphia, USA )
30 Oct 2026

Arcotatug tavatecan improves progression-free survival in CLDN18.2-positive advanced gastric cancer

Dr Kohei Shitara - National Cancer Center Hospital East, Kashiwa, Japan
Arcotatug tavatecan improves progression-free survival in CLDN18.2-positive advanced gastric cancer ( Dr Kohei Shitara - National Cancer Center Hospital East, Kashiwa, Japan )
26 Oct 2026

Zanidatamab plus chemotherapy improves overall survival in HER2-positive advanced gastroesophageal cancer

Dr Kohei Shitara - National Cancer Center Hospital East, Kashiwa, Japan
Zanidatamab plus chemotherapy improves overall survival in HER2-positive advanced gastroesophageal cancer ( Dr Kohei Shitara - National Cancer Center Hospital East, Kashiwa, Japan )
26 Oct 2026

Divarasib improves survival in previously treated KRAS G12C mutated advanced NSCLC

Dr Ferdinandos Skoulidis - The University of Texas MD Anderson Cancer Center, Houston, USA
Divarasib improves survival in previously treated KRAS G12C mutated advanced NSCLC ( Dr Ferdinandos Skoulidis - The University of Texas MD Anderson Cancer Center, Houston, USA )
26 Oct 2026

ESMO 2026: Highlights and analysis

Prof Bishal Gyawali - Queen's University, Kingston, Canada
ESMO 2026: Highlights and analysis ( Prof Bishal Gyawali - Queen's University, Kingston, Canada )
26 Oct 2026

Dostarlimab achieves durable complete clinical responses in dMMR/MSI-H locally advanced rectal cancer

Dr Meredith Pelster - Sarah Cannon Research Institute, Nashville, USA
Dostarlimab achieves durable complete clinical responses in dMMR/MSI-H locally advanced rectal cancer ( Dr Meredith Pelster - Sarah Cannon Research Institute, Nashville, USA )
26 Oct 2026

TALENT: Neoadjuvant T-DXd with or without anastrozole, or in sequence with chemo for HER2-low, HR+ early-stage breast cancer

Prof Sara Hurvitz - Fred Hutchinson Cancer Center, Seattle, USA
TALENT: Neoadjuvant T-DXd with or without anastrozole, or in sequence with chemo for HER2-low, HR+ early-stage breast cancer ( Prof Sara Hurvitz - Fred Hutchinson Cancer Center, Seattle, USA )
24 Oct 2026

Perioperative pembrolizumab fails to significantly improve event-free survival in muscle-invasive bladder cancer

Prof Jens Bedke - Klinikum Stuttgart-Katharinenhospital, Stuttgart, Germany
Perioperative pembrolizumab fails to significantly improve event-free survival in muscle-invasive bladder cancer ( Prof Jens Bedke - Klinikum Stuttgart-Katharinenhospital, Stuttgart, Germany )
24 Oct 2026

WCLC 2026: Lung cancer research highlights

Dr Luis Raez - Memorial Cancer Institute, Miami, USA
WCLC 2026: Lung cancer research highlights ( Dr Luis Raez - Memorial Cancer Institute, Miami, USA )
14 Oct 2026

Quality improvement initiative reduces chemotherapy wastage in paediatric oncology in Pakistan

Prof Alia Ahmad - The Children's Hospital Lahore, Lahore, Pakistan
Quality improvement initiative reduces chemotherapy wastage in paediatric oncology in Pakistan ( Prof Alia Ahmad - The Children's Hospital Lahore, Lahore, Pakistan )
24 Sep 2026